Lakefront Biotherapeutics NV (LKFT) stock
LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Financials through fiscal 2025, year ended Dec 31, 2025Score 7/30
$33.39−0.68 (-2.00%)
Close on Nov 19, 2026Market cap $2.20BP/E 6.2Yield –
Lakefront Biotherapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 66M, up 0.0% from the year before. Over ten years it grew 6.3% a year on average. The highest annual figure on record is 66M in fiscal 2024.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 66M | 0.0% |
| FY2024 | Dec 31, 2024 | 66M | +0.0% |
| FY2023 | Dec 31, 2023 | 66M | +0.3% |
| FY2022 | Dec 31, 2022 | 66M | +0.3% |
| FY2021 | Dec 31, 2021 | 66M | +0.7% |
| FY2020 | Dec 31, 2020 | 65M | +12.9% |
| FY2019 | Dec 31, 2019 | 58M | +10.6% |
| FY2018 | Dec 31, 2018 | 52M | +5.3% |
| FY2017 | Dec 31, 2017 | 49M | +4.6% |
| FY2016 | Dec 31, 2016 | 47M | +32.5% |
| FY2015 | Dec 31, 2015 | 36M | – |
See a number that looks wrong?